PLATELET AGGREGATION INHIBITORS
Clinical trials for PLATELET AGGREGATION INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new PLATELET AGGREGATION INHIBITORS trials appear
Sign up with your email to follow new studies for PLATELET AGGREGATION INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests simpler blood thinner regimen after heart procedure
Disease control Recruiting nowThis study compares two blood thinner strategies after left atrial appendage closure (LAAC) in people with atrial fibrillation. Sixty participants will receive either aspirin alone or aspirin plus clopidogrel for three months. The goal is to see which approach better prevents sma…
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Tailored blood thinners could save limbs in PAD patients
Disease control Recruiting nowThis study tests whether a personalized blood-thinning plan, guided by a blood test, can prevent dangerous blood clots better than the standard one-size-fits-all approach in people with peripheral artery disease who have had leg surgery. About 484 adults will be randomly assigned…
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a different aspirin regimen better protect diabetic hearts?
Disease control Recruiting nowThis study looks at whether changing the dose or form of aspirin can improve blood clotting control in people with type 2 diabetes who don't respond well to standard enteric-coated aspirin. About 30 participants will try three different aspirin regimens over several weeks. The ma…
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: PHASE1 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Smart algorithm aims to tailor blood thinner use after stents
Disease control Recruiting nowThis study tests whether a risk-score algorithm can safely personalize how long patients take dual antiplatelet therapy (two blood thinners) after getting a heart stent. About 2,788 participants will be assigned to either algorithm-guided or standard treatment duration. The goal …
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 26, 2026 17:59 UTC